Welcome to our dedicated page for Lifestance Health Group news (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on Lifestance Health Group stock.
LifeStance Health Group reports developments as a Nasdaq-listed provider of virtual and in-person outpatient mental healthcare. The company serves children, adolescents and adults through psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy.
Recurring news themes include quarterly operating results, visit volumes, clinician productivity, center-level margin trends, cash flow, debt and capital allocation. Company updates also cover secondary common stock offerings by selling stockholders, share repurchase activity, investor conference presentations, executive and board changes, and corporate-status announcements tied to its outpatient mental health services business.
LifeStance Health Group (NASDAQ: LFST) reported Q3 2022 revenue of $217.6 million, a 25% increase from Q3 2021. The company achieved a net loss of $37.9 million, significantly improved from $120.5 million a year prior, mainly due to $34.9 million in stock-based compensation. Adjusted EBITDA rose 44% to $15.4 million. Despite expanding its clinician base by 24% to 5,431, the company adjusted its 2022 revenue guidance to $845-$850 million, citing lower visit volumes and increased costs. LifeStance continues to focus on growth and operational improvements.
LifeStance Health (NASDAQ: LFST) announces J. Michael Bruff's transition to Business Transformation Officer, effective November 10, 2022, with David Bourdon succeeding him as Chief Financial Officer. This leadership shift aims to strengthen the company's focus on strategic initiatives to enhance operational efficiency and patient experience. Bourdon brings over 20 years of relevant experience from Magellan Health and Cigna, aligning with LifeStance's goals for growth and profitability in mental healthcare services.
LifeStance Health Group, Inc. (NASDAQ: LFST) is set to release its third quarter earnings on November 8, 2022, after market close. A live conference call will follow at 4:30 p.m. ET to discuss the results. Interested participants can join via a dedicated phone line or listen to the live audio webcast available on the LifeStance Investor Relations website. Founded in 2017, LifeStance is a leading provider of outpatient mental health care, employing around 5,200 mental health professionals across 32 states and approximately 600 centers.
LifeStance Health (NASDAQ: LFST) appointed Ken Burdick as CEO and Chairman, effective September 7, 2022, succeeding retiring founder Michael Lester, who will remain a Strategic Advisor. Burdick’s extensive 40-year healthcare experience includes leadership roles at Centene and WellCare. The transition aims to drive growth and enhance care access, supported by Danish Qureshi, now President and COO. LifeStance operates over 600 centers nationwide, employing around 5,200 clinicians, and emphasizes affordable, quality mental healthcare.
LifeStance Health Group, a leading provider of outpatient mental health care, announced its participation in the Morgan Stanley 20th Annual Global Healthcare Conference in New York City on September 13, 2022. Key presenters include CEO Michael Lester, COO Danish Qureshi, and CFO J. Michael Bruff. The presentation is scheduled for 9:10 a.m. (Eastern time) and will be webcast live, with a replay available afterward. Established in 2017, LifeStance operates around 600 centers in 32 states, employing about 5,200 professionals to enhance access to mental health services.
LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q2 2022 revenue of $209.5 million, a 31% increase from the previous year. The total clinician count rose to 5,226, with a net gain of 237 in the quarter. Despite a net loss of $68.7 million, a slight improvement from the prior year's loss, adjusted EBITDA remained steady at $14.6 million. The company expects full-year revenue and center margin towards the lower end of previous guidance due to changes in clinician availability. Full-year adjusted EBITDA guidance was reaffirmed at $63 million to $67 million.
LifeStance Health Group, Inc. (NASDAQ: LFST) will release its second quarter earnings after market close on August 9, 2022. A live earnings conference call is scheduled for the same day at 4:30 p.m. Eastern Time, accessible via phone or a real-time audio webcast on the Investor Relations website. LifeStance, founded in 2017, is a leading provider of outpatient mental health care, employing around 5,000 professionals across 500 centers in 32 states. The company aims to enhance access to affordable mental health services for individuals of all ages.
LifeStance Health Foundation has appointed Gwen Booth as its first Executive Director, effective July 1, 2022. Booth will focus on enhancing access to mental health services for vulnerable populations, including youth and underrepresented communities. The Foundation has granted over $400,000 to various organizations aiming to destigmatize mental health care. Booth's background includes leadership roles in healthcare, and she aims to address barriers to affordable mental healthcare, advancing the Foundation's mission to unify mental and physical healthcare.
LifeStance Health Group, Inc. (NASDAQ: LFST), a leading outpatient mental health care provider, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, 2022, at 11:20 a.m. PT. CEO Michael Lester, COO Danish Qureshi, and CFO J. Michael Bruff will present at the event moderated by Jamie Perse. Attendees can access the live webcast on LifeStance's Investor Relations website, where a replay will also be available. Danish Qureshi's appointment as COO takes effect on July 1, 2022.
LifeStance Health (NASDAQ: LFST) announces the retirement of COO Gwen Booth, who will become Executive Director of the LifeStance Health Foundation, which aims to improve mental health access. Danish Qureshi, previously Chief Growth Officer, has been appointed as the new COO effective July 1, 2022. Booth has been with the company since its founding in 2017. Qureshi has a strong track record in growing the company and enhancing mental health services. The Foundation, established in 2021, has already awarded over $400,000 to support mental health initiatives.